News
Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhD <li /> Dottie Caplan promoted to Executive Vi ...
RBC Capital slightly trimmed Vertex Pharmaceuticals’ price target from $423 to $420, but the firm’s rating stayed the course.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback